Locations:
Search IconSearch

Tag: monoclonal antibody

monoclonal antibody illustration
August 22, 2025/Cancer/Blood Cancers

New Essential Thrombocythemia Treatment Appears to Address Underlying Disease

Phase 1 study found mutant calreticulin-specific monoclonal antibody brings promising results with no dose-limiting toxicities

Myelofibrosis cells
March 18, 2025/Cancer/Blood Cancers

Personalizing Treatment of Myelofibrosis-Associated Anemia

Combination therapy may help address underlying disease

Dr. Littlejohn with patient

Emerging Treatments for Systemic Lupus Erythematosus

A review of expanding options that hold new promise

22-CNR-3001718-CQD-Hero-650x450S-WOG 1318 Phase 2 Trial
July 28, 2022/Cancer/Research

Phase 2 Study Shows Promise for Treating Older Adults with Ph-Negative B-ALL

Blinatumomab followed by POMP maintenance shows effectiveness for newly diagnosed patients

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Advanced Noninvasive Tools for the Diagnosis of Cardiac Amyloidosis: What’s Their Role?
January 14, 2021/Cancer/Benign Hematology

Combination Therapy Triggers Complete Hematological Response in Amyloidosis Patient

Finally, promising new therapies for this difficult disease

BackPage 1 of 1Next

Advertisement

Ad